期刊文献+

顺铂载入碳纳米管内增加其抗肿瘤性的研究 被引量:4

Study on the enhancement of anticancer effects of cisplatin by single-walled carbon nanotubes with larger diameters
下载PDF
导出
摘要 目的观察大孔径碳纳米管(SWNTs)做为载体以增加顺铂抗肿瘤活性的模式及机制。方法用毛细现象,将碘化丙啶(PI)和顺铂装载进入纳米管管腔,内载顺铂进入宫颈癌细胞,并在细胞内释放顺铂;用荧光分光光度计及紫外分光光度计,观察PI及顺铂在细胞外和细胞内释放模式,并通过流式细胞技术及MTT法,检测顺铂对宫颈癌细胞增殖活性的抑制。结果顺铂在碳纳米管的运载下,可较易进入细胞内,从而使细胞内药物浓度增加,其模式与PI的转载模式相同,且在顺铂浓度较低时,就可对Hela细胞产生明显的抑制作用。结论 SWNTs内载抗癌药物可逆转肿瘤耐药,增加药物抗肿瘤作用。 Objective To study the extracellular as well as the intracellular drug release mode,the drug delivery ability,and the anticancer potential of single-walled carbon nanotubes(SWNTs)with larger diameters(20-50 nm)loaded with cisplatin or propidium iodide(PI)in cervical cancer cells.Methods Determination of extracellular and intracellar PI and cisplatin release mode of drug-loaded SWNTs by UV spectrophotometer and fluorospectrophotometer.To observe the cytotoxic effect of cisplatin-loaded SWNTs on the proliferation of Hela cells by MTT assay and flow cytometry detection.Results Our findings was demonstrated that SWNTs with larger diameters(20-50 nm)has good membrane penetration and drug delivery abilities.Cisplatin-loaded SWNTs has a similar extracellular drug release mode to PI-loaded SWNTs,and cisplatin-loaded SWNTs can enhance the anticancer effects of cisplatin in cervical cancer cells in a concentration-dependent manner.Conclusion Our study was suggested that SWNTs with larger diameters(20-50 nm)is a good carrier for fluorescent reagents and therapeutic agents,and cisplatin-loaded SWNTs with larger diameters(20-50 nm)is a promising anti-cancer agent for cervical cancers.
出处 《中国临床药理学杂志》 CAS CSCD 北大核心 2010年第12期920-922,953,共4页 The Chinese Journal of Clinical Pharmacology
关键词 大孔径纳米管 顺铂 HELA细胞 增殖活性 single-walled carbon nanotubes with larger diameters cisplatin cervical cancer cell proliferation
  • 相关文献

参考文献10

  • 1Bianco A.Carbon nanotubes for the delivery of therapeutic molecules[J].Expt Opin Drug Deliv,2004;1:57-65.
  • 2Bianco A,Kostareles K,Partides CD,et al.Biomedical applications of funcitionalised carbon nanotub[J].Chem Commun,2005;5:571-577.
  • 3Bianeo A,Kestareles K,Partides CD,et al.Biomedical application of functionalised carbon nanotubes[J].Chem Commun,2005;7:571-577.
  • 4Kam NW,Liu Z,Dai H Carbon nanotubes as intraeellular trans porters for protein and DNA:an investigation of the uptake mechanism and pathway[J].Angew Chem Int Ed Engl,2005;45:577-581.
  • 5Lopez CF,Nielsen SO,Moore PB,et al.Understanding nature's design for nanesyringe[J].Proc Natl Acad Sci USA,2004;101:4431-4434.
  • 6Yakirevich E,Sabo E,Nareditsky I,et al.Muhidrug resistancerelated phenotype and apoptesis related protein expression in ovarian serous carcinomas[J].Gynecol Oncol,2006;100:152-159.
  • 7Liu Z,Chen K,Davis C,et al.Drug delivery with carbon nano-tubes for in vivo Caner treatment[J].Cancer Res,2008;68:6652.
  • 8Hampel S,Kunne D,Hsase D,et al.Carbon nanotubes filled with a chemotherapeutic agent:a nanocarrier mediates nhibition of tumor cell growth[J].Nanomed,2008;3:175.
  • 9Kestarelos K,Lacerda L,Pastorin G,et al.Cellular uptake of functionalized carbon nanotubes is independent of funbtional group and cell type[J].Nat Nanotechnol,2007;2:108-113.
  • 10Xiao H,Zou HF,Pan CS,et al.Quantitative determination of oxidized carbon nanotube probes in yeast by capillary electrophoresis with laser-induced fluorescence detection[J].AnalChim Acta,2006:580:194-199.

同被引文献46

  • 1李林,张志杰,蔡宝昌.中药百合有效部位的药效学筛选[J].南京中医药大学学报,2005,21(3):175-177. 被引量:19
  • 2姜德龙,迟安政,张启华.医用脱脂棉存在的问题及加强质量控制和监督的建议[J].中国医疗器械杂志,2005,29(5):364-365. 被引量:4
  • 3曹国颖,徐巧玲,傅得兴.多靶点抗肿瘤药物——培美曲塞二钠[J].药物不良反应杂志,2006,8(2):148-151. 被引量:20
  • 4唐棣华.抗癌药物顺铂抗癌机制的线索.化学研究与应用,2010,(1):96-96.
  • 5Burger AM,Double JA,Newell DR.Inhibition of tdomerase activity by Cisplatin in human tesficularoaneer cells[J].Eur J Cancer,1997,33(4):638- 644.
  • 6Mylonakis N,Athanasiou A,Ziras N ,et al. Phase H study of liposomal cisplatin (Lipoplatin) plus gemcitabine versus cisplatin plus gemcitabine as first line treatment in inoperable ( stage IIIB / IV) non-small cell lung cancedJ].Lung Cancer,2010,68(2):240.
  • 7Kosmas C,Angel J,Athanasiou A ,et al. 9 088 Phase III study of Lipoplatin plus Gemcitabine versus Cisplatin plus Gemcitabine in advanced NSCLC; interim anal[J].Eur J Cancer Suppl,2009,7(2):531.
  • 8Carla Tripisciano,Ewa Borowiak-Palen. Cisplatin functionalized singlewalled carbon nanotubes[J].physica status solidi.B,2008,245(10):1979- 1982.
  • 9Cheng K,Peng S,Xu CJ,et al.Porous Hollow Fe304 Nanoparticles for Targeted Delivery and Controlled Release of Cisplatin[J].Journal of the American Chemical Society,2009,131(30):10637-10644.
  • 10Arthur Taylor,Yulia Krupskaya,Kai Kramer.Cisplatin-loaded carbonencapsulated iron nanoparticlcs and their in vitro effects in magnetic fluid hyperthermia[J].Carbon,2010,48(8):2327-2334.

引证文献4

二级引证文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部